An in vivo Biomarker to Characterize Ototoxic Compounds and Novel Protective Therapeutics
Sign Up to like & getrecommendations! Published in 2022 at "Frontiers in Molecular Neuroscience"
DOI: 10.3389/fnmol.2022.944846
Abstract: There are no approved therapeutics for the prevention of hearing loss and vestibular dysfunction from drugs like aminoglycoside antibiotics. While the mechanisms underlying aminoglycoside ototoxicity remain unresolved, there is considerable evidence that aminoglycosides enter inner… read more here.
Keywords: biomarker; protective therapeutics; biomarker characterize; characterize ototoxic ... See more keywords